Pfizer Targets Monthly Obesity Shot. Why Lilly Could Still Have The Weight-Loss Heavyweight.Investors Business Daily • 02/03/26
Pfizer says once-a-month weight-loss drug works as it forecasts profit declineMarket Watch • 02/03/26
Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlookCNBC • 02/03/26
Pfizer's Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b TrialBusiness Wire • 02/03/26
Pfizer Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings CallBenzinga • 02/02/26
3 Top Dividend Stocks Yielding More Than 4% to Buy Hand Over Fist This YearThe Motley Fool • 01/30/26